Exploiting Protein Phosphatase Inhibitors Based on Cantharidin Analogues for Cancer Drug Discovery

By  

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 8, 2013-06 ,pp. : 1166-1176

Bentham Science Publishers

Access to resources Recommend Favorite

Contractility and Inhibition of Protein Phosphatases by Cantharidin - recent progress

By Knapp J.   Boknk P.   Huke S.   Gombosova I.   Linck B.   Luss H.   Muller F.U.   Muller T.   Nacke P.   Schmitz W.   Vahlensieck U.   Neumann J.  

General Pharmacology, Vol. 31, Iss. 5, 1998-11 ,pp. : 729-733

Elsevier

Access to resources Recommend Favorite

Synthesis and cytotoxicity of podophyllotoxin analogues modified in the A ring

By Castro A.   del Corral J.M.M.   Gordaliza M.   Grande C.   Gomez-Zurita A.   Garca-Gravalos D.   San Feliciano A.  

European Journal of Medicinal Chemistry, Vol. 38, Iss. 1, 2003-01 ,pp. : 65-74

Elsevier

Access to resources Recommend Favorite

Synthetic Strategy and Biological Activity of A-ring Stereoisomers of 1,25- Dihydroxyvitamin D3 and C2-Modified Analogues

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 21, 2014-11 ,pp. : 2446-2453

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological Inhibition of Protein Tyrosine Phosphatase 1B: A Promising Strategy for the Treatment of Obesity and Type 2 Diabetes Mellitus

By  

Current Medicinal Chemistry, Vol. 20, Iss. 21, 2013-01 ,pp. : 2609-2625

Bentham Science Publishers

Access to resources Recommend Favorite